| Code | 93619 | ||||||||||
| MA number | 21/0213/19-S | ||||||||||
| Product Form: | tbl mod 30x400 mg (blis.PVC/PE/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | Novartis Slovakia s.r.o., Slovakia | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/PE/PVDC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 22.11.1988 |
| Pediatric posology: | Yes |
| PIL: |
PIL_Tegretol CR_10.2022.pdf
|
| SPC: |
SPC_Tegretol CR_10.2022.pdf
|
| Safety feature | Yes |
| Data update: | 08.07.2019 |
